Bristol-Myers Squibb Company (BMY) - Financial and Strategic SWOT Analysis Review

Date: September 13, 2016
Pages: 89
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B637F6D38AAEN
Leaflet:

Download PDF Leaflet

Bristol-Myers Squibb Company (BMY) - Financial and Strategic SWOT Analysis Review
Bristol-Myers Squibb Company (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company, which focuses on innovative drugs to address unmet medical needs of patients with serious diseases. It discovers, develops, licenses, manufactures, markets and distributes biopharmaceuticals and related healthcare products. Its product line includes chemically-synthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/AIDS and rheumatoid arthritis. The company offers its products across the world through a network of wholesalers, retail pharmacies, hospitals and government entities. BMS has research and development facilities in the US, Belgium, England, France and Japan; and has manufacturing facilities in Puerto Rico, the US, France, Italy, Ireland, Japan, Mexico and China. BMS is headquartered in New York, the US.

Bristol-Myers Squibb Company Key Recent Developments

Jul 28, 2016: Bristol-Myers Squibb Reports Second Quarter Financial Results
Jul 25, 2016: Bristol-Myers Squibb Appoints Fouad Namouni, M.D., Oncology Development Head
Jul 18, 2016: Publication of HPTN 052 final results
Jul 01, 2016: Major Biopharmaceutical Signs up to a MedAdvisor Patient Engagement Program
Jun 21, 2016: BMS and Biogen to Give Biomanufacturing Keynote Presentations at CHI's Eighth Annual The Bioprocessing Summit

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Bristol-Myers Squibb Company - Key Facts
Bristol-Myers Squibb Company - Key Employees
Bristol-Myers Squibb Company - Key Employee Biographies
Bristol-Myers Squibb Company - Major Products and Services
Bristol-Myers Squibb Company - Pharmaceutical Pipeline Products Data
Bristol-Myers Squibb Company, Pipeline Products by Therapy Area
Bristol-Myers Squibb Company, Pipeline Products by Development Phase
Bristol-Myers Squibb Company - History
Bristol-Myers Squibb Company - Company Statement
Bristol-Myers Squibb Company - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Bristol-Myers Squibb Company - Business Description
Bristol-Myers Squibb Company - Corporate Strategy
Bristol-Myers Squibb Company - SWOT Analysis
SWOT Analysis - Overview
Bristol-Myers Squibb Company - Strengths
Strength - Focused R&D Activities
Strength - Blockbuster Drugs
Bristol-Myers Squibb Company - Weaknesses
Weakness - Loss of Exclusivity: Baraclude
Weakness - Cost Control
Bristol-Myers Squibb Company - Opportunities
Opportunity - Agreements and Collaborations
Opportunity - Inorganic Growth
Opportunity - New Product Approvals
Opportunity - Strategic Partnerships
Bristol-Myers Squibb Company - Threats
Threat - Reliance on Distributors
Threat - Rise of Generics
Threat - Stringent Government Regulations
Bristol-Myers Squibb Company - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Bristol-Myers Squibb Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Bristol-Myers Squibb Company, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Bristol-Myers Squibb Company, Medical Equipment, Deals By Year, 2010 to YTD 2016
Bristol-Myers Squibb Company, Medical Equipment, Deals By Type, 2010 to YTD 2016
Bristol-Myers Squibb Company, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jul 28, 2016: Bristol-Myers Squibb Reports Second Quarter Financial Results
Jul 25, 2016: Bristol-Myers Squibb Appoints Fouad Namouni, M.D., Oncology Development Head
Jul 18, 2016: Publication of HPTN 052 final results
Jul 01, 2016: Major Biopharmaceutical Signs up to a MedAdvisor Patient Engagement Program
Jun 21, 2016: BMS and Biogen to Give Biomanufacturing Keynote Presentations at CHI's Eighth Annual The Bioprocessing Summit
Jun 20, 2016: Murdo Gordon Appointed Executive Vice President and Chief Commercial Officer
Jun 01, 2016: Bristol-Myers Squibb Executive to Discuss New Data-Driven Approach to Driving Sales Excellence at 2016 LTEN Conference
May 25, 2016: Allied Minds announces successful completion of ABLS II drug candidate feasibility programme and approval of up to $15 million to fund further drug development
May 19, 2016: Inovalon Announces Agreement with Bristol-Myers Squibb to Focus on Real World Outcomes & Value-Based Contracting Initiatives
May 17, 2016: Bristol-Myers Squibb Opens Expanded Biologics Facility

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Bristol-Myers Squibb Company, Key Facts
Bristol-Myers Squibb Company, Key Employees
Bristol-Myers Squibb Company, Key Employee Biographies
Bristol-Myers Squibb Company, Major Products and Services
Bristol-Myers Squibb Company, Number of Pipeline Products by Therapy Area
Bristol-Myers Squibb Company, Number of Pipeline Products by Development Stage
Bristol-Myers Squibb Company, Pipeline Products By Therapy Area and Development Phase
Bristol-Myers Squibb Company, History
Bristol-Myers Squibb Company, Other Locations
Bristol-Myers Squibb Company, Subsidiaries
Bristol-Myers Squibb Company, Joint Venture
Bristol-Myers Squibb Company, Key Competitors
Bristol-Myers Squibb Company, Ratios based on current share price
Bristol-Myers Squibb Company, Annual Ratios
Bristol-Myers Squibb Company, Interim Ratios
Bristol-Myers Squibb Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Bristol-Myers Squibb Company, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Bristol-Myers Squibb Company, Medical Equipment, Deals By Year, 2010 to YTD 2016
Bristol-Myers Squibb Company, Medical Equipment, Deals By Type, 2010 to YTD 2016
Bristol-Myers Squibb Company, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Bristol-Myers Squibb Company, Pipeline Products by Therapy Area
Bristol-Myers Squibb Company, Pipeline Products by Development Phase
Bristol-Myers Squibb Company, Performance Chart (2011 - 2015)
Bristol-Myers Squibb Company, Ratio Charts
Bristol-Myers Squibb Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Bristol-Myers Squibb Company, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Bristol-Myers Squibb Company, Medical Equipment, Deals By Year, 2010 to YTD 2016
Bristol-Myers Squibb Company, Medical Equipment, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Bristol-Myers Squibb Company (BMY) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: